Business Context and Reporting Period
SeaStar Medical Holding Corp (ICU) filed a Form 8-K on December 11, 2023, reporting an "Other Event" under Item 8.01. The filing details the execution of a Second Amendment to a Securities Purchase Agreement (SPA) with an institutional investor and the completion of an Additional Closing.
Key Financial Metrics and Transaction Details
The filing discloses specific terms of a new financing tranche but does not provide consolidated revenue, profit, cash flow, or margin data for the reporting period.
- Convertible Note Issued: Principal amount of $1,086,956.52.
- Initial Conversion Price: $0.56 per share.
- Conversion Start Date: June 11, 2024, or earlier upon mutual agreement or an Event of Default.
- Warrants Issued: Two separate warrants, each for up to 527,708 shares of Common Stock (total 1,055,416 shares).
- Warrant Exercise Price: $0.56 per share.
Material Changes Versus Prior Period
This filing represents a continuation of the financing arrangement established in the First Amendment to the SPA (August 8, 2023) and the original SPA (March 15, 2023). The material change is the issuance of additional debt and equity instruments under the existing framework, increasing the total capital raised from this specific investor.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond the standard terms of the convertible note (e.g., Event of Default). The transaction is structured to provide liquidity through convertible debt and warrants.
Key Facts for Investor Verification
- Verify the total aggregate principal amount of notes outstanding under the SPA after this closing.
- Confirm the dilution impact of the 1,055,416 new warrants and the potential conversion of the $1.09M note at the $0.56 price.
- Review prior 8-K filings (March 16, August 7, August 30, September 26, and November 27, 2023) for the full history of the SPA terms and previous closings.
- Check the company's current cash position to assess the immediate use of proceeds from this tranche.